Oracle's $553 Billion Backlog: A Double-Edged Sword for Investors
10.04.2026 - 16:03:57 | boerse-global.deOracle's stock is caught in a curious tug-of-war. While a recent unsolicited mini-tender offer from TRC Capital highlights near-term market skepticism, the company's own books tell a story of unprecedented, yet risky, long-term ambition. The software giant finds itself navigating a path defined by record-breaking cloud contracts and a financial profile straining under the weight of its own expansion.
The operational figures from its third fiscal quarter are undeniably strong. Total revenue surged 22% to $17.2 billion, powered by its cloud segment. More staggering is the remaining performance obligation (RPO), or backlog, which ballooned 325% year-over-year to approximately $553 billion. Management has raised its revenue outlook for fiscal 2027 to $90 billion, forecasting that Oracle Cloud Infrastructure could scale to $144 billion within five years—a target largely backed by this booked backlog.
Beneath this growth lies a significant concentration risk. A full $300 billion of that colossal backlog is tied to a single customer: OpenAI. This dependency raises eyebrows, given the AI firm's own estimated annualized revenue of $25 billion and its history of losses, prompting questions about the long-term viability of such a massive commitment.
Should investors sell immediately? Or is it worth buying Oracle?
Funding this aggressive infrastructure build-out comes at a steep cost. The investment program has pushed free cash flow deep into negative territory at -$24.74 billion. To cover capital needs, long-term debt has climbed to $124.7 billion, up from $85.3 billion, with the company recently raising $30 billion through bonds and preferred stock. The market has taken note; the cost to insure Oracle's debt against default hit record levels near 166 basis points during the quarter, though some analysts believe future earnings growth can offset the higher leverage.
This financial strain coincides with pronounced weakness in the share price. The stock has shed roughly half its value since its September peak and is down about 29% year-to-date, recently trading around €117.18. It is against this backdrop that TRC Capital made its offer to purchase up to one million shares at $140.50 each—a 2.2% discount to the market price at the time of announcement. Oracle has rejected the offer and advised shareholders to consult financial advisors and check current market prices before acting. The tender, for less than 0.04% of outstanding shares, runs until April 22, 2026.
Despite these headwinds, Wall Street sentiment remains overwhelmingly positive. Of 44 analysts covering the stock, 33 rate it a Buy, with only one recommending a Sell. Mizuho recently affirmed a $400 price target, citing Oracle's clear infrastructure advantage in the AI sector.
Internally, Oracle is taking steps to manage its balance sheet. The appointment of Hilary Maxson as the new CFO in early April was followed by plans for layoffs expected to generate $8 to $10 billion in cost savings, earmarked for debt service and further infrastructure investment. Shareholders can also look forward to the company's consistent dividend, with the next quarterly payment of $0.50 per share scheduled for April 24, 2026. Oracle has increased its dividend for twelve consecutive years, boasting a five-year average growth rate of 15.81%.
Ad
Oracle Stock: New Analysis - 10 April
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Oracles Aktien ein!
Für. Immer. Kostenlos.
